Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-000755

Chief Financial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2022-12-30 Option exercise +5,000 $6.88 $34,400 36,667 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
FRATES JAMES M Chief Financial Officer 2022-12-30 Option exercise · Stock Option (Right to Buy) −5,000 447,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…